Clinicopathologic Features of Peripheral T-Cell Lymphoma in Sub-Saharan Africa.
Epstein-Barr virus
Low/middle-income countries
Peripheral T-cell lymphoma
Sub-Saharan Africa
Journal
American journal of clinical pathology
ISSN: 1943-7722
Titre abrégé: Am J Clin Pathol
Pays: England
ID NLM: 0370470
Informations de publication
Date de publication:
17 06 2021
17 06 2021
Historique:
pubmed:
3
2
2021
medline:
27
8
2021
entrez:
2
2
2021
Statut:
ppublish
Résumé
Peripheral T-cell lymphomas (PTCLs) are heterogeneous, clinically aggressive, and rare. Subtype distribution varies by geographic location; however, data from sub-Saharan Africa (SSA) are lacking. We sought to elucidate clinicopathologic features of PTCL in SSA. We reviewed PTCL consultation cases from three SSA countries. PTCL subtype was determined per 2017 World Health Organization classification. Cases with sufficient material were evaluated by polymerase chain reaction for human T-cell leukemia virus type 1 (HTLV-1) and T-cell receptor γ (TCRG) rearrangement. Among 32 cases, median age was 45 years and male-to-female ratio was 1.7. Thirty (94%) of 32 cases required additional workup for subclassification. PTCL, not otherwise specified (PTCL-NOS) was the most common subtype (13/32, 41%), followed by PTCL with T-follicular helper phenotype (6/32, 19%) and systemic anaplastic large cell lymphoma (6/32, 19%). Four (16%) of 25 cases were Epstein-Barr virus positive (EBV+) (2/2 extranodal natural killer/T-cell lymphoma, 1/13 PTCL-NOS, and 1/4 angioimmunoblastic T-cell lymphoma with EBV+ immunoblasts). Two (15%) of 13 patients with PTCL-NOS were human immunodeficiency virus positive. No cases with evaluable DNA (0/15) were HTLV-1 positive, and 9 of 10 showed clonal TCRG rearrangements. In comparison to Western studies, PTCLs from SSA show similar subtype distribution and male predominance but a younger age at diagnosis. Appropriate diagnosis of PTCL requires extensive ancillary testing not readily available in low-income countries, including much of SSA.
Identifiants
pubmed: 33527979
pii: 6126238
doi: 10.1093/ajcp/aqaa201
pmc: PMC8209619
doi:
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
42-55Informations de copyright
© American Society for Clinical Pathology, 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Lancet. 2010 Oct 2;376(9747):1186-93
pubmed: 20709386
J Glob Oncol. 2019 May;5:1-8
pubmed: 31045473
Curr Opin HIV AIDS. 2017 Jan;12(1):89-95
pubmed: 27607593
Br J Haematol. 2011 Sep;154(6):696-703
pubmed: 21707579
Br J Cancer. 2015 Apr 28;112(9):1575-84
pubmed: 25867256
J Am Acad Dermatol. 2009 Mar;60(3):359-75; quiz 376-8
pubmed: 19231637
Ann Oncol. 2004 Oct;15(10):1467-75
pubmed: 15367405
Am J Surg Pathol. 2008 Nov;32(11):1593-607
pubmed: 18753947
Arch Pathol Lab Med. 2007 Nov;131(11):1636-9
pubmed: 17979479
Rev Bras Hematol Hemoter. 2012;34(1):42-7
pubmed: 23049383
Am J Clin Pathol. 2010 Apr;133(4):592-601
pubmed: 20231613
J Clin Diagn Res. 2015 Jun;9(6):EC14-9
pubmed: 26266128
Int J Hematol. 2016 Nov;104(5):591-595
pubmed: 27456462
Haematologica. 2017 Apr;102(4):e148-e151
pubmed: 28082343
Histopathology. 1993 Feb;22(2):145-9
pubmed: 8384155
J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):460-6
pubmed: 21239997
Front Microbiol. 2012 Nov 15;3:388
pubmed: 23162541
Br J Dermatol. 2017 Jun;176(6):1653-1656
pubmed: 27529394
Exp Ther Med. 2017 Jul;14(1):567-574
pubmed: 28672968
Curr Hematol Malig Rep. 2016 Dec;11(6):492-503
pubmed: 27995419
J Clin Oncol. 2008 Sep 1;26(25):4124-30
pubmed: 18626005
Hematol Oncol Stem Cell Ther. 2015 Jun;8(2):78-84
pubmed: 25450840
Br J Haematol. 2016 Mar;172(5):716-23
pubmed: 26898194
J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1020-7
pubmed: 15247554
Int J Cancer. 2010 Mar 1;126(5):1187-95
pubmed: 19688826
Blood. 2012 May 31;119(22):5078-87
pubmed: 22461494
Haematologica. 2015 Sep;100(9):e361-4
pubmed: 26045291
Front Oncol. 2018 Jun 13;8:211
pubmed: 29951372
Sci Total Environ. 2012 Apr 15;423:214-28
pubmed: 21071068
JAMA Netw Open. 2019 May 3;2(5):e194337
pubmed: 31150073
J Natl Compr Canc Netw. 2013 Mar 1;11(3):275-280
pubmed: 23486453
Hum Pathol. 2018 Apr;74:5-16
pubmed: 29337025
Curr Hematol Malig Rep. 2018 Feb;13(1):25-36
pubmed: 29442288
Arch Dermatol. 2007 Jul;143(7):854-9
pubmed: 17638728
Blood Adv. 2016 Nov 22;1(1):84-92
pubmed: 29296697
Am J Surg Pathol. 2013 Jun;37(6):816-26
pubmed: 23598959
Hum Pathol. 1998 Nov;29(11):1285-9
pubmed: 9824108
Afr Health Sci. 2006 Jun;6(2):69-75
pubmed: 16916294
Ann Diagn Pathol. 2018 Dec;37:107-117
pubmed: 30317149
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593